ArticleAnnals of translational medicine2018
Lowering low-density lipoprotein cholesterol by PCSK9 inhibition in patients with diabetes on insulin therapy: is it efficacious and safe?
Michel FarnierPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.